A C Frazier-Wood1, E K Kabagambe, M K Wojczynski, I B Borecki, H K Tiwari, C E Smith, J M Ordovas, D K Arnett. 1. Department of Epidemiology, University of Alabama at Birmingham, School of Public Health, Birmingham, AL 35294, United States; Division of Epidemiology, Human Genetics and Environmental Sciences, The University of Texas School of Public Health, Houston, TX 77030, United States. Electronic address: Lekki.Wood@Gmail.com.
Abstract
BACKGROUND AND AIMS: In vitro studies suggest that low density lipoprotein receptor-related protein 1 (LRP1) plays a role in the secondary uptake of chylomicrons. In addition, in vivo studies using LRP-1 knockout mice show these animals exhibit delayed chylomicron clearance. Whether this is true in humans is unknown. We aimed to determine whether genetic variants in LRP-1 are associated with postprandial chylomicron uptake in humans given an oral fat challenge. METHODS AND RESULTS: As many as 817 men and women (mean age +/- standard deviation = 48.4 +/- 16.4 years) forming the study population for the Genetics of Lipid Lowering Drugs Network (GOLDN) study ingested an oral fat load of 700 kilocalories per m² of body surface area at 83% fat, after an 8-h fast. Chylomicrons were measured by nuclear resonance spectroscopy (NMR) at fasting, and 3.5 and 6 h after the meal. 26 Single nucleotide polymorphisms (SNPs) in the LRP-1 gene were genotyped on the Affymetrix 6.0 array. Chylomicrons were, as expected, zero at fasting. Mixed linear models adjusted for age, sex, study site and pedigree tested for associations between LRP-1 SNPs and changes in chylomicron concentrations 3.5-6 h. A gene-based test across all 26 SNPs was conducted which corrected for the linkage disequilibrium (LD) between SNPs. 11 LRP-1 SNPs were significantly associated with the change in chylomicron concentration correction for multiple testing (Q < 0.05). The subsequent gene-based test, was also significant (P = 0.01). CONCLUSION: These results require replication but strongly indicate the role of LRP1 in postprandial lipoprotein uptake and/or clearance.
BACKGROUND AND AIMS: In vitro studies suggest that low density lipoprotein receptor-related protein 1 (LRP1) plays a role in the secondary uptake of chylomicrons. In addition, in vivo studies using LRP-1 knockout mice show these animals exhibit delayed chylomicron clearance. Whether this is true in humans is unknown. We aimed to determine whether genetic variants in LRP-1 are associated with postprandial chylomicron uptake in humans given an oral fat challenge. METHODS AND RESULTS: As many as 817 men and women (mean age +/- standard deviation = 48.4 +/- 16.4 years) forming the study population for the Genetics of Lipid Lowering Drugs Network (GOLDN) study ingested an oral fat load of 700 kilocalories per m² of body surface area at 83% fat, after an 8-h fast. Chylomicrons were measured by nuclear resonance spectroscopy (NMR) at fasting, and 3.5 and 6 h after the meal. 26 Single nucleotide polymorphisms (SNPs) in the LRP-1 gene were genotyped on the Affymetrix 6.0 array. Chylomicrons were, as expected, zero at fasting. Mixed linear models adjusted for age, sex, study site and pedigree tested for associations between LRP-1 SNPs and changes in chylomicron concentrations 3.5-6 h. A gene-based test across all 26 SNPs was conducted which corrected for the linkage disequilibrium (LD) between SNPs. 11 LRP-1 SNPs were significantly associated with the change in chylomicron concentration correction for multiple testing (Q < 0.05). The subsequent gene-based test, was also significant (P = 0.01). CONCLUSION: These results require replication but strongly indicate the role of LRP1 in postprandial lipoprotein uptake and/or clearance.
Authors: Jimmy Z Liu; Allan F McRae; Dale R Nyholt; Sarah E Medland; Naomi R Wray; Kevin M Brown; Nicholas K Hayward; Grant W Montgomery; Peter M Visscher; Nicholas G Martin; Stuart Macgregor Journal: Am J Hum Genet Date: 2010-07-09 Impact factor: 11.025
Authors: Jérome Terrand; Véronique Bruban; Li Zhou; Wanfeng Gong; Zeina El Asmar; Petra May; Kai Zurhove; Philipp Haffner; Claude Philippe; Estelle Woldt; Rachel L Matz; Céline Gracia; Daniel Metzger; Johan Auwerx; Joachim Herz; Philippe Boucher Journal: J Biol Chem Date: 2008-11-06 Impact factor: 5.157
Authors: Randall J Pruim; Ryan P Welch; Serena Sanna; Tanya M Teslovich; Peter S Chines; Terry P Gliedt; Michael Boehnke; Gonçalo R Abecasis; Cristen J Willer Journal: Bioinformatics Date: 2010-07-15 Impact factor: 6.937
Authors: Michael Y Tsai; Angeliki Georgopoulos; James D Otvos; Jose M Ordovas; Naomi Q Hanson; James M Peacock; Donna K Arnett Journal: Clin Chem Date: 2004-05-13 Impact factor: 8.327
Authors: Asier Benito-Vicente; Kepa B Uribe; Shifa Jebari; Unai Galicia-Garcia; Helena Ostolaza; Cesar Martin Journal: Int J Mol Sci Date: 2018-11-01 Impact factor: 5.923
Authors: Katarzyna J Siemienowicz; Panagiotis Filis; Sophie Shaw; Alex Douglas; Jennifer Thomas; Sally Mulroy; Forbes Howie; Paul A Fowler; W Colin Duncan; Mick T Rae Journal: Sci Rep Date: 2019-12-27 Impact factor: 4.379